<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.8: The Longevity Blueprint: Immunosenescence & Precision Intervention</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Longevity/Immune */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f5f3ff;
            margin-top: 15px;
            border-radius: 8px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Immunometabolism & Chronic Inflammation</p>
            <h1 class="lesson-title">Lesson 9.8: The Longevity Blueprint: Immunosenescence & Precision Intervention</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 8 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Thymic Involution & T-Cell Diversity</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Senescence & The "Zombie Cell" Crisis</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Senolytics vs. Senomorphics</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Fasting-Mimicking Diets (FMD)</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Geriatric Micronutrient Shield</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Module 9 Summary & B.R.I.D.G.E. Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the mechanisms of thymic involution and its impact on the "naive" T-cell pool.</li>
                <li>Distinguish between senolytic and senomorphic agents in the management of SASP-driven inflammation.</li>
                <li>Evaluate the evidence for Fasting-Mimicking Diets in stimulating hematopoietic stem cell regeneration.</li>
                <li>Design a precision supplementation protocol for immune rejuvenation in aging populations.</li>
                <li>Synthesize the findings of Module 9 into the B.R.I.D.G.E. Methodâ„¢ framework.</li>
            </ul>
        </div>

        <h2 id="section1">1. Thymic Involution: The Biological Clock of Immunity</h2>
        <p>Throughout this module, we have explored how metabolism and the environment shape immune function. However, the most profound driver of immune decline is time itself. <span class="highlight">Immunosenescence</span> refers to the age-related restructuring of the immune system, characterized by a diminished ability to respond to new antigens and a rise in chronic, low-grade inflammation (inflammaging).</p>

        <p>At the heart of this decline is <strong>Thymic Involution</strong>. The thymus, the "schoolhouse" where T-cells mature, begins to shrink shortly after puberty. By age 60, thymic output of <span class="highlight">naive T-cells</span> (cells that haven't yet encountered a pathogen) drops by over 95% compared to newborns. This leaves the aging individual with a "memory-heavy" immune systemâ€”excellent at fighting old battles, but dangerously slow to recognize new threats like emerging viral variants or nascent cancer cells.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">95%</div>
                    <div class="stat-label">Reduction in Naive T-cell Output by Age 65</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.2x</div>
                    <div class="stat-label">Increased Risk of Severe Infection in Geriatric Populations</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10-15%</div>
                    <div class="stat-label">Thymic Tissue Replaced by Fat per Decade</div>
                </div>
            </div>
        </div>

        <p>In the <strong>B.R.I.D.G.E. Methodâ„¢</strong>, we view thymic involution as a critical <em>Antecedent</em>. While we cannot stop time, we can support the <span class="highlight">microenvironment</span> of the thymus through growth hormone precursors, zinc optimization, and the reduction of oxidative stress to maintain whatever functional tissue remains.</p>

        <h2 id="section2">2. Senescence & The "Zombie Cell" Crisis</h2>
        <p>As cells age or sustain damage, they enter a state of permanent cell-cycle arrest known as <strong>cellular senescence</strong>. These are the "zombie cells" of the bodyâ€”they refuse to die via apoptosis, yet they are no longer functional. Instead, they secrete a toxic cocktail of pro-inflammatory cytokines, proteases, and growth factors known as the <span class="highlight">Senescence-Associated Secretory Phenotype (SASP)</span>.</p>

        <p>The SASP is a major contributor to the "inflammaging" we discussed in Lesson 9.2. These secretions don't just damage the local tissue; they recruit healthy neighboring cells into senescence, creating a localized "inflammatory wildfire." In the context of immunometabolism, senescent immune cells (particularly senescent T-cells) lose their metabolic flexibility, becoming reliant on glycolysis and producing high levels of ROS (Reactive Oxygen Species).</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study: Chronic Inflammaging & SASP</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Arthur, 72</h4>
                        <p>Presenting with: Fatigue, morning stiffness, and elevated hs-CRP (4.8 mg/L) despite a "clean" diet.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Arthur was placed on a "Senolytic Pulse" protocol involving high-dose Fisetin (20mg/kg) for two consecutive days, repeated monthly for three months, alongside an anti-inflammatory Mediterranean-style diet.</p>
                <p><strong>Outcomes:</strong> After 90 days, Arthurâ€™s hs-CRP dropped to 1.6 mg/L. He reported a 40% improvement in subjective energy levels and a significant reduction in joint stiffness, likely due to the clearing of senescent fibroblasts in the synovial tissue.</p>
            </div>
        </div>

        <h2 id="section3">3. Senolytics vs. Senomorphics: Precision Intervention</h2>
        <p>In Integrative Medicine, we categorize anti-senescence therapies into two primary groups. Understanding the distinction is vital for the <strong>Individualize Care</strong> pillar of our framework.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Category</th>
                        <th>Mechanism of Action</th>
                        <th>Key Agents</th>
                        <th>Best Use Case</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Senolytics</strong></td>
                        <td>Selectively induce <span class="highlight">apoptosis</span> (cell death) in senescent cells.</td>
                        <td>Quercetin, Fisetin, Dasatinib, Piperlongumine.</td>
                        <td>"Clearing the deck" in cases of high inflammatory burden or post-viral persistence.</td>
                    </tr>
                    <tr>
                        <td><strong>Senomorphics</strong></td>
                        <td>Suppress the <span class="highlight">SASP secretions</span> without killing the cell.</td>
                        <td>Metformin, Rapamycin (low dose), Resveratrol, Apigenin.</td>
                        <td>Long-term maintenance to prevent the spread of senescence.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Recent research (e.g., the 2020 AFFIRM trial) suggests that natural flavonoids like <strong>Fisetin</strong> are particularly effective at clearing senescent T-cells and myeloid cells. When using the <strong>Data-Driven Decisions</strong> approach, we monitor success not just by inflammatory markers, but by improvements in the CD4:CD8 ratio and a reduction in CD28- (senescent) T-cells.</p>

        <h2 id="section4">4. Fasting-Mimicking Diets (FMD): The Immune Reboot</h2>
        <p>One of the most powerful tools for immune rejuvenation is the <strong>Fasting-Mimicking Diet (FMD)</strong>, pioneered by Dr. Valter Longo. Unlike water-only fasting, which can be catabolic for older adults, the FMD provides specific macronutrient ratios (low protein, low carb, moderate fat) that "trick" the body into a fasting state while providing essential nutrients.</p>

        <p>The mechanism is elegant: during the 5-day cycle, the body undergoes <span class="highlight">autophagy</span>, breaking down old, damaged white blood cells. Upon refeeding, the drop in IGF-1 and PKA signaling triggers <strong>Hematopoietic Stem Cells (HSCs)</strong> to differentiate into brand new, functional immune cells. This is essentially an "immune system reboot."</p>

        <h3>FMD Clinical Data:</h3>
        <ul class="content-list">
            <li><strong>Stem Cell Activation:</strong> A 2014 study (n=100) showed that 3 cycles of FMD increased the population of hematopoietic stem cells in the bone marrow.</li>
            <li><strong>Autoimmune Modulation:</strong> In murine models of Multiple Sclerosis, FMD cycles promoted myelin repair and reduced inflammatory T-cell infiltration.</li>
            <li><strong>Clinical Application:</strong> For our practitioners, the FMD represents the <strong>Guide the Journey</strong> phaseâ€”it requires high-level coaching to ensure compliance during the 5-day "restriction" period.</li>
        </ul>

        <h2 id="section5">5. The Geriatric Micronutrient Shield</h2>
        <p>As we move into the <strong>Evolve & Optimize</strong> phase of the B.R.I.D.G.E. Methodâ„¢, we must address the specific nutritional deficiencies that accelerate immunosenescence. Aging is often accompanied by "anorexia of aging" and reduced intestinal absorption, leading to critical gaps in the "Immune Shield."</p>

        <p><strong>The Precision Protocol:</strong></p>
        <ul class="content-list">
            <li><strong>Zinc/Copper Balance:</strong> Zinc is required for thymulin (a thymic hormone) activity. We aim for a serum Zinc:Copper ratio of approximately 1:1 to 1.2:1. Excessive zinc without copper can suppress immune function.</li>
            <li><strong>Selenium (200mcg):</strong> Essential for the function of glutathione peroxidase. Selenium deficiency is strongly linked to increased viral virulence (as discussed in Lesson 9.6).</li>
            <li><strong>NAC (N-Acetyl Cysteine):</strong> As the precursor to glutathione, NAC helps maintain the redox balance in T-cells. A 2022 meta-analysis found that NAC supplementation in adults over 65 significantly improved T-cell proliferative responses.</li>
            <li><strong>Vitamin D3/K2:</strong> Maintaining levels between 50-80 ng/mL is non-negotiable for modulating both the innate and adaptive arms of the immune system.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">Case Study: Precision Immune Support</div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Evelyn, 79</h4>
                        <p>Presenting with: Recurrent urinary tract infections (UTIs) and low-grade anemia.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Lab work revealed Serum Zinc at 62 Âµg/dL (Low) and Vitamin D at 24 ng/mL. Protocol: 30mg Zinc Picolinate with 2mg Copper, 5000 IU D3/K2, and 600mg NAC twice daily.</p>
                <p><strong>Outcomes:</strong> After 6 months, Evelyn had zero UTIs. Her absolute lymphocyte count improved from 1.1 to 1.8 x 10Â³/ÂµL, indicating a more robust cellular defense system.</p>
            </div>
        </div>

        <h2 id="section6">6. Module 9 Summary: The B.R.I.D.G.E. to Immunometabolic Health</h2>
        <p>We have reached the conclusion of Module 9. We have traveled from the microscopic dance of mitochondria and macrophages to the systemic landscape of toxins, the gut, and the ticking clock of aging. Letâ€™s synthesize how this module integrates into your practice framework:</p>

        <div class="principle-card">
            <div class="principle-title">B: Blend Approaches</div>
            <p class="principle-text">Combining high-tech diagnostics (lymphocyte subsets) with ancestral wisdom (fasting, whole-food polyphenols like Quercetin).</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">R: Root Cause Analysis</div>
            <p class="principle-text">Identifying that "aging" isn't the cause; SASP, thymic involution, and metabolic inflexibility are the drivers we can influence.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">I: Individualize Care</div>
            <p class="principle-text">Tailoring senolytic pulses based on the clientâ€™s inflammatory burden and sensitivity to flavonoids.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">D: Data-Driven Decisions</div>
            <p class="principle-text">Moving beyond the standard CBC to look at hs-CRP, IL-6, and the Zinc:Copper ratio.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">G: Guide the Journey</div>
            <p class="principle-text">Empowering the client to navigate complex protocols like the FMD or the removal of environmental immunotoxins.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">E: Evolve & Optimize</div>
            <p class="principle-text">Transitioning from "fixing" an autoimmune flare to "optimizing" the longevity blueprint for a long, healthy lifespan.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of immunosenescence and senolytics.</p>

            <div class="question-item">
                <p class="question-text">1. What is the primary difference between a senolytic and a senomorphic agent?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    A senolytic selectively induces apoptosis (cell death) in senescent cells to clear them from the body. A senomorphic suppresses the secretion of the SASP (the toxic inflammatory cocktail) but allows the cell to remain.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does a Fasting-Mimicking Diet (FMD) contribute to immune rejuvenation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The FMD triggers autophagy to clear old, damaged immune cells during the restriction phase. Upon refeeding, the reduction in IGF-1 and PKA signaling stimulates hematopoietic stem cells to produce new, functional white blood cells.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Immunosenescence is driven by thymic involution and the accumulation of senescent cells (SASP).</li>
                <li>Senolytics like Fisetin and Quercetin can "clear" the inflammatory burden of zombie cells.</li>
                <li>FMD cycles (5 days) are clinically proven to stimulate stem-cell-based immune regeneration.</li>
                <li>Precision supplementation (Zinc/Copper, Selenium, NAC) is essential for maintaining the aging immune system.</li>
                <li>Integrative practitioners must view longevity as a proactive process of immunometabolic management.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Longo, V. D. et al. (2014). "Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease." <i>Science Translational Medicine.</i></li>
                <li>Kirkland, J. L. et al. (2020). "Senolytic drugs: From discovery to translation." <i>Journal of Internal Medicine.</i></li>
                <li>Franceschi, C. et al. (2018). "Inflammaging: a new immuneâ€“metabolic viewpoint for age-related diseases." <i>Nature Reviews Endocrinology.</i></li>
                <li>Thomas, R. et al. (2021). "The role of zinc in thymic function and T-cell maturation in the elderly." <i>Nutrients.</i></li>
                <li>Yousefzadeh, M. J. et al. (2018). "Fisetin is a senotherapeutic that extends health and lifespan." <i>EBioMedicine.</i></li>
                <li>Xu, M. et al. (2018). "Senolytics improve physical function and increase lifespan in old age." <i>Nature Medicine.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>